{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:20:08Z","timestamp":1793388008461,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7531","license":[{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2014,12,18]]},"DOI":"10.1038\/nature13902","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T06:37:13Z","timestamp":1413873433000},"page":"423-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":601,"title":["In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR\/Cas9 system"],"prefix":"10.1038","volume":"516","author":[{"given":"Danilo","family":"Maddalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eusebio","family":"Manchado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla P.","family":"Concepcion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana A.","family":"Vidigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Chi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ogrodowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"BFnature13902_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.cco.0000198972.69541.04","volume":"18","author":"T Taki","year":"2006","unstructured":"Taki, T. & Taniwaki, M. Chromosomal translocations in cancer and their relevance for therapy. Curr. Opin. Oncol. 18, 62\u201368 (2006)","journal-title":"Curr. Opin. Oncol."},{"key":"BFnature13902_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda, M. et al. Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer. Nature 448, 561\u2013566 (2007)","journal-title":"Nature"},{"key":"BFnature13902_CR3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak, E. L. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693\u20131703 (2010)","journal-title":"N. Engl. J. Med."},{"key":"BFnature13902_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0959-437X(01)00272-6","volume":"12","author":"DA Tuveson","year":"2002","unstructured":"Tuveson, D. A. & Jacks, T. Technologically advanced cancer modeling in mice. Curr. Opin. Genet. Dev. 12, 105\u2013110 (2002)","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnature13902_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrd2110","volume":"5","author":"NE Sharpless","year":"2006","unstructured":"Sharpless, N. E. & Depinho, R. A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nature Rev. Drug Discov. 5, 741\u2013754 (2006)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature13902_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.celrep.2014.04.014","volume":"7","author":"V Pirazzoli","year":"2014","unstructured":"Pirazzoli, V. et al. Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Cell Rep. 7, 999\u20131008 (2014)","journal-title":"Cell Rep."},{"key":"BFnature13902_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers, G. & Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nature Rev. Cancer 8, 592\u2013603 (2008)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature13902_CR8","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1073\/pnas.0702955104","volume":"104","author":"S Rottenberg","year":"2007","unstructured":"Rottenberg, S. et al. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc. Natl Acad. Sci. USA 104, 12117\u201312122 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13902_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp, N. et al. Acute leukaemia in bcr\/abl transgenic mice. Nature 344, 251\u2013253 (1990)","journal-title":"Nature"},{"key":"BFnature13902_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.1771409","volume":"23","author":"J Zuber","year":"2009","unstructured":"Zuber, J. et al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 23, 877\u2013889 (2009)","journal-title":"Genes Dev."},{"key":"BFnature13902_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.onc.1206076","volume":"22","author":"K Lange","year":"2003","unstructured":"Lange, K. et al. Overexpression of NPM\u2013ALK induces different types of malignant lymphomas in IL-9 transgenic mice. Oncogene 22, 517\u2013527 (2003)","journal-title":"Oncogene"},{"key":"BFnature13902_CR12","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2002-05-1343","volume":"101","author":"R Chiarle","year":"2003","unstructured":"Chiarle, R. et al. NPM\u2013ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101, 1919\u20131927 (2003)","journal-title":"Blood"},{"key":"BFnature13902_CR13","doi-asserted-by":"publisher","first-page":"19893","DOI":"10.1073\/pnas.0805381105","volume":"105","author":"M Soda","year":"2008","unstructured":"Soda, M. et al. A mouse model for EML4\u2013ALK-positive lung cancer. Proc. Natl Acad. Sci. USA 105, 19893\u201319897 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13902_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","volume":"85","author":"J Corral","year":"1996","unstructured":"Corral, J. et al. An Mll\u2013AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85, 853\u2013861 (1996)","journal-title":"Cell"},{"key":"BFnature13902_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng0495-376","volume":"9","author":"AJ Smith","year":"1995","unstructured":"Smith, A. J. et al. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nature Genet. 9, 376\u2013385 (1995)","journal-title":"Nature Genet."},{"key":"BFnature13902_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/embo-reports\/kvd021","volume":"1","author":"EC Collins","year":"2000","unstructured":"Collins, E. C., Pannell, R., Simpson, E. M., Forster, A. & Rabbitts, T. H. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep. 1, 127\u2013132 (2000)","journal-title":"EMBO Rep."},{"key":"BFnature13902_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1101\/gr.147314.112","volume":"23","author":"M Piganeau","year":"2013","unstructured":"Piganeau, M. et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res. 23, 1182\u20131193 (2013)","journal-title":"Genome Res."},{"key":"BFnature13902_CR18","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/ncomms4964","volume":"5","author":"R Torres","year":"2014","unstructured":"Torres, R. et al. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nature Commun. 5, 3964 (2014)","journal-title":"Nature Commun."},{"key":"BFnature13902_CR19","doi-asserted-by":"publisher","first-page":"10620","DOI":"10.1073\/pnas.0902076106","volume":"106","author":"E Brunet","year":"2009","unstructured":"Brunet, E. et al. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl Acad. Sci. USA 106, 10620\u201310625 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13902_CR20","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/ncomms4728","volume":"5","author":"PS Choi","year":"2014","unstructured":"Choi, P. S. & Meyerson, M. Targeted genomic rearrangements using CRISPR\/Cas technology. Nature Commun. 5, 3728 (2014)","journal-title":"Nature Commun."},{"key":"BFnature13902_CR21","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-07-6158","volume":"68","author":"YL Choi","year":"2008","unstructured":"Choi, Y. L. et al. Identification of novel isoforms of the EML4\u2013ALK transforming gene in non-small cell lung cancer. Cancer Res. 68, 4971\u20134976 (2008)","journal-title":"Cancer Res."},{"key":"BFnature13902_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.1179555","volume":"327","author":"P Horvath","year":"2010","unstructured":"Horvath, P. & Barrangou, R. CRISPR\/Cas, the immune system of bacteria and archaea. Science 327, 167\u2013170 (2010)","journal-title":"Science"},{"key":"BFnature13902_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012)","journal-title":"Science"},{"key":"BFnature13902_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013)","journal-title":"Science"},{"key":"BFnature13902_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 263, 1281\u20131284 (1994)","journal-title":"Science"},{"key":"BFnature13902_CR26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage, M., Dooley, A. L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nature Protocols 4, 1064\u20131072 (2009)","journal-title":"Nature Protocols"},{"key":"BFnature13902_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1038\/modpathol.2012.109","volume":"25","author":"M Nishino","year":"2012","unstructured":"Nishino, M. et al. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas. Modern Pathol. 25, 1462\u20131472 (2012)","journal-title":"Modern Pathol."},{"key":"BFnature13902_CR28","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson, E. L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243\u20133248 (2001)","journal-title":"Genes Dev."},{"key":"BFnature13902_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2291","volume":"8","author":"R Chiarle","year":"2008","unstructured":"Chiarle, R., Voena, C., Ambrogio, C., Piva, R. & Inghirami, G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nature Rev. Cancer 8, 11\u201323 (2008)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature13902_CR30","doi-asserted-by":"publisher","first-page":"21312","DOI":"10.1074\/jbc.M114.564625","volume":"289","author":"MC Canver","year":"2014","unstructured":"Canver, M. C. et al. Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells. J. Biol. Chem. 289, 21312\u201321324 (2014)","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1038\/nature14571","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature13902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13902","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature13902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:26:13Z","timestamp":1684419973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature13902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":30,"journal-issue":{"issue":"7531","published-print":{"date-parts":[[2014,12,18]]}},"alternative-id":["BFnature13902"],"URL":"https:\/\/doi.org\/10.1038\/nature13902","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.723553043.793503387","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]},"assertion":[{"value":"28 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}